期刊
CURRENT OPINION IN GENETICS & DEVELOPMENT
卷 48, 期 -, 页码 22-29出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2017.10.003
关键词
-
资金
- Castilla-Leon Government [BIO/SA01/15, CSI049U16]
- Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2015-64556-R, RD12/0036/0002]
- Worldwide Cancer Research [14-1248]
- Ramon Areces Foundation
- Spanish Society Against Cancer
- MINECO [BFU2014-52729-P]
- European Regional Development Fund
Increasing evidence suggests that alterations in ribosome biogenesis (RiBi) confer competitive advantages to cancer cells. This has led to the discovery of regulatory layers mediated by signaling proteins, oncoproteins, and tumor suppressors whose deregulation leads to increased RiBi rates in cancer cells. In addition to boosting protein synthesis, these alterations probably contribute to shape the protumorigenic proteome of cancer cells. Mutations negatively affecting RiBi are also unexpectedly found in some spontaneous and ribosomopathy-associated tumors. The advantages provided by these genetic lesions to cancer cells remain unsettled as yet. Efforts are being made nowadays to exploit RiBi-associated vulnerabilities and tumor suppressor pathways to design new therapeutic avenues. In this review, we will summarize the main developments and pending challenges in this research area.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据